欢迎访问《中国真菌学杂志》杂志官方网站,今天是 分享到:

中国真菌学杂志 2013, Vol. 8  Issue (4): 220-222,227.

论著 上一篇    下一篇

美浮特® 皮肤抗菌液治疗足癣开放多中心临床观察

王冲1, 李明2, 王秀丽3, 许爱娥4, 施辛5, 曾荣1, 占萍1, 王乐1, 沈永年1, 吕桂霞1, 刘维达1   

  1. 1. 中国医学科学院/北京协和医学院皮肤病医院真菌科, 南京 210042;
    2. 复旦大学附属中山医院, 上海 200032;
    3. 上海市皮肤病医院, 上海 200443;
    4. 杭州市第三人民医院, 杭州 310009;
    5. 苏州大学附属第二医院, 苏州 215004
  • 收稿日期:2013-06-15 出版日期:2013-08-28 发布日期:2013-08-28
  • 通讯作者: 刘维达,E-mail:liumyco@hotmail.com E-mail:liumyco@hotmail.com
  • 作者简介:王冲,男(汉族),博士研究生在读.E-mail:pumcderm11@163.com

Meifute® Antifungal Solution in the treatment of tinea pedis:an open, multicentre trial

WANG Chong1, LI Ming2, WANG Xiu-li3, XU Ai-e4, SHI Xin5, ZENG Rong1, ZHAN Ping1, WANG Le1, SHEN Yong-nian1, LV Gui-xia1, LIU Wei-da1   

  1. 1. Department of mycology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210042, China;
    2. Department of Dermatology, Zhongshan Hospital, Dudan University, Shanghai 200032, China;
    3. Department of Dermatology, Shanghai Skin Diseases Hospital, Shanghai 200443, China;
    4. Department of Dermatology, Third Hospital of Hangzhou, Hangzhou 310009, China;
    5. Department of Dermatology, 2nd affiliated Hospital, Soochow university, Suzhou 214004, China
  • Received:2013-06-15 Online:2013-08-28 Published:2013-08-28

摘要: 目的 观察美浮特® 皮肤抗菌液在治疗足癣的临床疗效及安全性。方法 采用开放、多中心方法。5家中心共计入组126例足癣患者。64例趾间糜烂型足癣患者一次性使用美浮特® 皮肤抗菌液浸足2 h;62例鳞屑角化型患者使用2次,每次2 h,使用间隔7 d。分别于基线 (V0),1周 (V1),2周 (V2),3周 (V3)记录症状和体征总积分 (Total Symptom Score,TSS)变化率以及真菌镜检、培养转阴情况来评价综合疗效、临床疗效和真菌学疗效。结果 V3时,总真菌学清除率为92.86%。4个访视点总TSS评分分别为10.12±3.25,4.95±2.72,2.63±1.99和1.24±1.53,呈逐步下降趋势,治疗前后TSS差异有统计学意义 (t=30.87,P<0.005)。痊愈51例 (40.48%),显效64例 (50.79%),进步11例 (8.73%),总体有效率为91.27%。共发生疼痛20例次,瘙痒5例次,水肿2例次,烧灼感1例次,未经任何处理,以上不良反应均可自行缓解。结论 美浮特® 皮肤抗菌液治疗足癣有效,安全性好。

关键词: 抗真菌药, 足癣, 治疗

Abstract: Objective To investigate the efficacy and safety of Meifute® Antifungal Solution in the treatment of tinea pedis.Methods A open,multicentre trial was conducted in 5 muticentre.A total of 126 patients was enrolled.The patients with interdigital tinea pedis were applied once, and The patients with hyperkeratotic tinea pedis were applied twice interval of one week.Global efficacy,clinical improvement and mycological cure was assessed in terms of total symptom score (TSS), mycology determination (KOH and dermatophyte culture) at baseline, 1,2 and 3 weeks after treatment.Results After treatment, mycological cure rate was 92.86%,TSS in four interview point, was 10.12±3.25,4.95±2.72,2.63±1.99和1.24±1.53 respectively,demonstrate a decreasing tendency,there is a significant defference in TSS between before and after treatment (t=30.87,P<0.005). Cure rates, effective rates and improved rates were 40.48%,50.79% and 8.73% respectively,the global efficacy was 91.27%. Incidence of adverse events was low, and the symptoms, including pain (20 cases/time), pruritus (5 cases/time), edema (2 cases/time) causalgia (1 cases/time),is confined and self-regressive.Conclusion These findings indicate that Meifute® Antifungal Solution was highly safe and effective in the treatment of tinea pedis.

Key words: antifungal agents, tinea pedis, therapies

中图分类号: